A clinical study TO evaluate the efficacy of AYUSH drug on Covid 19 patients
Phase 2
Completed
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/08/035908
- Lead Sponsor
- Sri Sri Institute for advanced research Begaluru Karnataka
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
History of fever
Cough
Willingness to participate in the study
Patient should be ready to give written consent
Indian Nationals
Exclusion Criteria
Age less than 18 years or more than 65 years
Pregnancy and Lactation
T2DM
CVS disorders
Renal Problems(CKD)
COPD
Bronchial Asthma
Malignancy
CVA
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method RTPCR NEGATIVE <br/ ><br>Reducing the signs and symptoms and changes in biomarkersTimepoint: Day5 <br/ ><br>Day10
- Secondary Outcome Measures
Name Time Method trial drug will be more effective than placebo <br/ ><br>change in biomarkersTimepoint: DAY 1 <br/ ><br>DAY 5 <br/ ><br>DAY 10